Development Level

Tbio 3 | 10,625
Tchem 1 | 1,890
Tclin 1 | 602

IMPC Term

abnormal embryo size 1 | 112
abnormal retina morphology 1 | 100
abnormal retinal pigmentation 1 | 61
abnormal tooth morphology 1 | 24
decreased circulating glucose ... 1 | 121
decreased circulating serum al... 1 | 79
decreased circulating sodium l... 1 | 18
increased circulating HDL chol... 1 | 63
increased circulating LDL chol... 1 | 15
increased circulating alkaline... 1 | 119
increased circulating bilirubi... 1 | 16
increased circulating choleste... 1 | 53
increased circulating free fat... 1 | 17
increased circulating triglyce... 1 | 24
increased hemoglobin content 1 | 45
increased mean corpuscular hem... 1 | 25
preweaning lethality, complete... 1 | 633
small adrenal glands 1 | 15

Disease

ovarian cancer 5 | 8,484
glioblastoma 4 | 5,572
invasive ductal carcinoma 4 | 2,950
lung cancer 4 | 4,466
Alzheimer's disease 3 | 644
Atherosclerosis 3 | 275
Cardiovascular system disease 3 | 194
Coronary artery disease 3 | 240
Down syndrome 3 | 548
Hypercholesterolemia 3 | 27
Hypercholesterolemia, Familial 3 | 16
Hyperlipidemia 3 | 25
Lipid metabolism disorder 3 | 102
Metabolic syndrome X 3 | 155
Obesity 3 | 616
atypical teratoid / rhabdoid tumor 3 | 4,369
cystic fibrosis 3 | 1,665
diabetes mellitus 3 | 1,663
lung carcinoma 3 | 2,844
osteosarcoma 3 | 7,933
primary Sjogren syndrome 3 | 789
psoriasis 3 | 6,685
sarcoidosis 3 | 358
subependymal giant cell astrocytoma 3 | 2,287
ulcerative colitis 3 | 2,087
Age related macular degeneration 2 | 84
Cardiovascular Diseases 2 | 50
Coronary heart disease 2 | 59
Duchenne muscular dystrophy 2 | 602
Hyperlipoproteinemia Type IIa 2 | 7
IGA Glomerulonephritis 2 | 454
Neurodegenerative disease 2 | 383
Peripheral Neuropathy 2 | 303
Vascular disease 2 | 281
acute quadriplegic myopathy 2 | 1,157
adrenocortical carcinoma 2 | 1,427
astrocytoma 2 | 1,493
ductal carcinoma in situ 2 | 1,745
group 3 medulloblastoma 2 | 2,254
head and neck cancer and chronic obstructive pulmonary disease 2 | 237
interstitial cystitis 2 | 2,299
intraductal papillary-mucinous carcinoma (IPMC) 2 | 2,988
intraductal papillary-mucinous neoplasm (IPMN) 2 | 3,289
juvenile dermatomyositis 2 | 1,189
lung adenocarcinoma 2 | 2,713
malignant mesothelioma 2 | 3,162
medulloblastoma, large-cell 2 | 6,234
non-small cell lung cancer 2 | 2,798
oligodendroglioma 2 | 2,849
pancreatic ductal adenocarcinoma liver metastasis 2 | 1,795
pediatric high grade glioma 2 | 2,712
pilocytic astrocytoma 2 | 3,086
posterior fossa group B ependymoma 2 | 1,530
tuberculosis 2 | 1,557
AMYOTROPHIC LATERAL SCLEROSIS 1 1 | 49
Adenocarcinoma 1 | 115
Allergic rhinitis (disorder) 1 | 12
Aphasia 1 | 22
Atopic dermatitis 1 | 944
Brain disease 1 | 83
Cerebellar Ataxia 1 | 72
Cerebral amyloid angiopathy 1 | 9
Cerebrovascular disease 1 | 231
Colorectal Neoplasms 1 | 217
Dementia 1 | 129
Drug-Induced Liver Injury 1 | 118
Fatty Liver 1 | 48
Fatty liver disease 1 | 84
Gaucher disease type 1 1 | 171
Gout 1 | 93
Heart disease 1 | 279
Hyperglycemia 1 | 120
Hyperhomocysteinemia 1 | 34
Hyperplasia 1 | 26
Hypertension 1 | 287
Hypertensive disease 1 | 193
Kidney disease 1 | 396
Leishmaniasis 1 | 49
Liver disease 1 | 219
Lung Neoplasms 1 | 171
Lupus erythematosus 1 | 80
Lysosomal storage disease 1 | 11
Multiple Sclerosis 1 | 498
Myocardial Infarction 1 | 126
Nerve Degeneration 1 | 73
Non-alcoholic Fatty Liver Disease 1 | 40
Parkinson's disease 1 | 364
Proteinuria 1 | 63
Seizure Adverse Event 1 | 19
Seizures 1 | 95
Spontaneous abortion 1 | 108
Toxic encephalopathy 1 | 131
Tularemia 1 | 22
Type 2 diabetes mellitus 1 | 189
active ulcerative colitis 1 | 477
facioscapulohumeral dystrophy 1 | 286
hearing impairment 1 | 40
medulloblastoma 1 | 1,524
progressive supranuclear palsy 1 | 674
type II diabetes mellitus and post-ischemic heart failure 1 | 89

Tissue

Blood and immune system 5 | 17,995
Cardiovascular System 5 | 17,958
Digestive Tract 5 | 18,473
Endocrine System 5 | 18,512
Female tissues 5 | 18,647
Liver and Pancreas 5 | 18,136
Male tissues 5 | 17,969
Nervous System 5 | 18,561
Respiratory system 5 | 17,484
Skin and soft tissues 5 | 18,115
Urinary Tract 5 | 18,444

Target Family

Non-IDG 4 | 11,971
Transporter 1 | 473

Grant Application

4R37HL064159-16 5 | 5
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Apolipoprotein E APOE Tbio Non-IDG -4.17470 15380.4 788
Low-density lipoprotein receptor LDLR Tchem Non-IDG -3.03661 893.1 512
Epididymal secretory protein E1 NPC2 Tbio Non-IDG -2.21852 163.4 153
Interferon-inducible protein AIM2 AIM2 Tbio Non-IDG -2.26799 140.7 401
ATP-binding cassette sub-family A member 1 ABCA1 Tclin Transporter -3.10569 1383.2 302